Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2012
06/27/2012CN102512694A Biological preparation for resisting against replication and infection of foot-and-mouth disease virus and preparation method as well as application thereof
06/27/2012CN102512693A Preparation method of porcine epidemic diarrhea recombinant adenovirus vaccine
06/27/2012CN102512686A Vaccine protectant, hydrophobia vaccine and preparation method thereof
06/27/2012CN102512685A Vaccine protection agent, and combined measles and Japanese encephalitis vaccine and preparation method thereof
06/27/2012CN102512675A Method for treating multiple sclerosis
06/27/2012CN102512674A Fish broad-spectrum vibrio subunit vaccine and preparation method
06/27/2012CN102512673A Injectable artemisia pollen allergen vaccine and preparation method thereof
06/27/2012CN102512672A Artemisia pollen allergen vaccine and preparation method thereof
06/27/2012CN102512671A Anti-foot-and-mouth disease type O virus-like particle vaccine and preparation method thereof
06/27/2012CN102512670A Streptococcus pyogenes antigens
06/27/2012CN102198270B Preparation method of aluminum-containing adjuvant hepatitis B vaccine
06/27/2012CN102154367B Swine influenza virus H3N2 and H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
06/27/2012CN102021146B West nile virus NS1 protein monoclonal antibody, identified B cell epitope thereof and application
06/27/2012CN101993492B ScFv antibody for resisting H5N1 type highly-pathogenic avian influenza and application thereof
06/27/2012CN101972479B Preparation process of intravenous injection human immunoglobulin
06/27/2012CN101972474B Freeze dried herpes zoster attenuated live vaccine and preparation method
06/27/2012CN101966341B Adenovirus/viruses A replicon chimeric vector hogcholeravaccine and application thereof
06/27/2012CN101948812B Eosinophilic kidney type avian infectious bronchitis virus (IBV) virulent vaccine strain and application thereof
06/27/2012CN101934073B Bovine viral diarrhea virus (BVDV) transgenosis astragalus mongholicus vaccine and production method
06/27/2012CN101906163B Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
06/27/2012CN101879317B Preparation method and application of Vibro harveyi and Vibrio parahaemolyticus bigeminy DNA vaccine
06/27/2012CN101870725B MAGE (Melanoma Antigen Gene)-4 anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof
06/27/2012CN101816785B Preparation method and product of H9N2 subtype avian influenza inactivated vaccine
06/27/2012CN101724074B Humanized chimeric antibody of angiostatin receptor beta subunit, preparation thereof and application thereof
06/27/2012CN101591393B Hydrophobia-tetanus double titer human immunoglobulin, method for preparing same and application thereof in pharmacy
06/27/2012CN101466406B Use of alpha-toxin for treating and preventing staphylococcus infections
06/27/2012CN101460623B Novel anti-CD98 antibody
06/27/2012CN101420975B Vaccine against mycoplasma PRRSV
06/27/2012CN101392232B Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine
06/27/2012CN101343320B Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof
06/27/2012CN101072582B Alpha thymosin peptides as cancer vaccine adjuvants
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207315 Expression vector comprising nucleotide sequence coding angiogenic factor (VG5Q protein) for use in identifying modulators which reduce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activity and treat or prevent cell proliferative disorders
06/26/2012US8207314 Tumor antigens for prevention and/or treatment of cancer
06/26/2012US8207311 Ovr115 antibody compositions and methods of use
06/26/2012US8207310 Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereof
06/26/2012US8207303 Monoclonal antibodies against CD30 lacking in fucosyl residues
06/26/2012US8207300 CTSP cancer-testis antigens
06/26/2012US8207135 Compositions for and methods of enhancing the immune response to antigens
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8206950 Fusion antigen used as vaccine and method of making them
06/26/2012US8206726 Zwitterionic polysaccharides for promotion of immune system maturation and health
06/26/2012US8206725 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP
06/26/2012US8206724 Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
06/26/2012US8206722 Somatostatin receptor antagonists and glucose control or hypoglycemia
06/26/2012US8206720 Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206717 Antibodies against IL-25
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206715 Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206713 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
06/26/2012US8206712 Use of anti-IL-20 antibody for treating rheumatoid arthritis
06/26/2012US8206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
06/26/2012US8206710 Anti-mesothelin antibodies
06/26/2012US8206709 Anti-NKG2A antibodies and uses thereof
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206707 Combination therapy for the treatment of ocular neovascular disorders
06/26/2012US8206706 Method for enhancing or inhibiting insulin-like growth factor-I
06/26/2012US8206705 KIM-1 antibodies for treatment of TH2-mediated conditions
06/26/2012US8206704 Use of GCC ligands
06/26/2012US8206701 Human leukocyte antigen (HLA); into which proteins and/or peptides or RNA or DNA or cDNA encoding the proteins and/or peptides which are overexpressed in tumor cells or which are derived from tumor cells have been introduced
06/26/2012US8206685 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
06/26/2012CA2605629C Nipah virus vaccines
06/26/2012CA2526950C Method for determining immune system affecting compounds
06/26/2012CA2406853C Methods and compositions for eliciting an immune response
06/26/2012CA2406225C Recombinant intracellular pathogen vaccines and methods for use
06/26/2012CA2405537C Vaccine comprising a tick cement protein
06/26/2012CA2343980C Mammaglobin, a secreted mammary-specific breast cancer protein
06/21/2012WO2012082918A1 Adenovirus serotype 26 and serotype 35 filovirus vaccines
06/21/2012WO2012082841A2 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
06/21/2012WO2012082752A2 Anti-ccl25 and anti-ccr9 antibodies for the prevention and treatment of cancer and cancer cell migration
06/21/2012WO2012082634A1 Vaccine antigens that direct immunity to conserved epitopes
06/21/2012WO2012082470A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
06/21/2012WO2012082237A1 Immunization with amyloid-beta oligomers
06/21/2012WO2012082165A1 Irradiated biodegradable polymer microparticles
06/21/2012WO2012082073A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012WO2012081947A2 Vaccine for inducing an improved immune reaction
06/21/2012WO2012080987A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012WO2012080986A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012WO2012080769A1 Anti-cd277 antibodies and uses thereof
06/21/2012WO2012080696A1 Vaccine
06/21/2012WO2012080642A1 Use of an antibody directed against a membrane protein
06/21/2012WO2012080444A1 Method for suppressing an immune response
06/21/2012WO2012080370A1 Mycobacterium antigenic composition
06/21/2012WO2012080369A1 Mycobacterium antigenic composition
06/21/2012WO2012080351A1 Anti-cd277 antibodies and uses thereof
06/21/2012WO2012080306A1 Cd89 activation in therapy
06/21/2012WO2012079878A2 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
06/21/2012WO2012058220A3 Anti-sod1 antibodies and uses thereof
06/21/2012WO2012054907A3 Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
06/21/2012WO2012051111A3 Human oncostatin m antibodies and methods of use
06/21/2012WO2012050944A9 Methods of treating chronic prostatitis/chronic pelvic pain syndrome
06/21/2012WO2012049317A3 Cytomegalovirus gb antigen
06/21/2012WO2012048152A3 Probiotic therapies for autism
06/21/2012WO2012047294A3 Antibodies directed against hla-b27 homodimers and methods and uses thereof in diagnosis and therapy
06/21/2012WO2012040164A3 Tlr5 ligands, therapeutic methods, and compositions related thereto
06/21/2012WO2012038504A3 Breast cancer therapeutics
06/21/2012WO2012037078A3 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 1823